Case Overview

Type: Roundup — New Lawsuits & Recalls

Published: April 2026

Cases Covered: 3

Verticals: Pharmaceutical / Food Safety / Drug Recalls

Drug Lawsuits and Recalls to Know: CVS Kickback Allegations, Salmonella-Contaminated Chia Seeds, and a Children's Ibuprofen Recall

Three significant legal and safety developments emerged in early April 2026, touching millions of American consumers — from patients who rely on pharmacy benefit managers to set drug costs, to parents who may have purchased a recalled children's pain reliever. The cases span allegations of corporate kickbacks, food contamination, and pharmaceutical manufacturing failures.

Here's what you need to know about each development.

1. CVS Health / CaremarkPCS — Alleged Kickbacks for Drug Formulary Access

Filed: April 2026

Who May Be Affected: Consumers and health plan members whose drug coverage was administered through CVS Caremark PBM services

Estimated Payout: Not yet determined — litigation is in early stages

A new class action lawsuit alleges that CVS Health Corp. and its pharmacy benefit manager (PBM) subsidiary, CaremarkPCS Health LLC, sold preferred placement on their drug formularies in exchange for kickbacks from pharmaceutical manufacturers. A formulary is a list of prescription drugs covered by a health plan — and where a drug lands on that list can significantly affect what patients pay out of pocket.

The lawsuit alleges that this arrangement prioritized drugs based on manufacturer payments rather than clinical value or cost-effectiveness to patients, potentially steering consumers toward more expensive or less appropriate medications. According to the complaint, this practice may have caused health plan members to pay more than they should have for prescription drugs.

Pharmacy benefit managers have faced growing scrutiny from federal regulators and legislators in recent years over their pricing practices and opaque relationships with drug manufacturers. This lawsuit represents the latest legal challenge to how PBMs influence drug access and cost.

What to do next: The case is in its early stages. Those who obtained prescription drug coverage through CVS Caremark-administered plans may want to monitor this litigation for updates.

2. Navitas Organics Chia Seeds — Salmonella Contamination Class Action

Filed: April 2026

Who May Be Affected: Consumers who purchased Navitas Organics chia seed products subject to the recall

Estimated Payout: Not yet determined — litigation is in early stages

A new class action lawsuit alleges that Navitas Organics failed to disclose that its chia seeds were contaminated with Salmonella, a bacterial pathogen that can cause serious illness — particularly in young children, older adults, and people with weakened immune systems.

According to the complaint, the company sold chia seed products that were later subject to a recall due to potential Salmonella contamination, but allegedly did not adequately warn consumers before the recall was issued. The lawsuit claims that had consumers known about the potential contamination risk, they would not have purchased the products — or would have paid significantly less for them.

The U.S. Food and Drug Administration has noted that Salmonella infections can cause diarrhea, fever, and abdominal cramps, and may require hospitalization in severe cases. The agency advises consumers not to eat recalled products and to check their pantries if they purchased affected lots.

What to do next: Consumers who purchased Navitas Organics chia seeds should check the FDA's recall database for affected product lot numbers. Those who believe they experienced illness after consuming the product may wish to consult a healthcare provider.

3. Strides Pharma — Children's Ibuprofen Recall (Nearly 90,000 Bottles)

Recall Issued: April 2026

Who May Be Affected: Parents and caregivers who purchased Strides Pharma Children's Ibuprofen Oral Suspension

Estimated Payout: No lawsuit announced yet — recall is the primary development

Strides Pharma has issued a voluntary recall of nearly 90,000 bottles of Children's Ibuprofen Oral Suspension after reports of contamination with foreign substances. The recall affects specific lot numbers of the product, which is commonly used to reduce fever and relieve minor pain in children.

While no lawsuit has been publicly announced as of this writing, recalls of this scale involving a medication intended for children frequently attract class action scrutiny. Plaintiffs in similar cases have alleged that manufacturers failed to maintain adequate quality control standards, and that consumers were misled about the safety and purity of the products they purchased.

The FDA classifies recalls based on the health risk posed by the defect. Consumers who purchased the affected product are encouraged to stop use, check lot numbers against the official recall notice, and contact Strides Pharma or their retailer for information on returns or refunds.

What to do next: Check the FDA's MedWatch database or Strides Pharma's official communications for affected lot numbers. If your child experienced any adverse effects after taking this product, consult a healthcare provider and consider reporting the incident to the FDA's MedWatch program.

Key Takeaways

• The CVS Caremark case targets the pharmacy benefit manager industry, which has faced intensifying regulatory scrutiny over its role in determining what drugs consumers can access and at what cost.
• Food contamination lawsuits often don't require proof of illness — purchasing a recalled product may be sufficient to participate in a class action, though eligibility determinations are made by attorneys on a case-by-case basis.
• Children's product recalls tend to generate significant legal activity. If litigation follows the Strides Pharma recall, class members may include anyone who purchased affected lot numbers, regardless of whether harm occurred.
• All three developments are recent — none have reached the settlement or claims-filing stage. Monitoring these cases over the coming months will be important for affected consumers.
• Proof of purchase matters. Consumers who retain receipts, packaging, or product lot numbers are generally better positioned if a settlement is eventually reached.

This article is for informational purposes only and does not constitute legal or medical advice. If you believe you have been harmed by any of the products or practices described above, consult a licensed attorney in your jurisdiction. If you have health concerns related to any recalled product, contact a qualified healthcare provider.

Have you been affected by any of these cases? Share your experience in the comments below.